Skye Bioscience Operating Income

Skye Bioscience (SKYE) currently reports a operating income of $-59M as of March 2026. That compares with $-22M in the prior-year period — down 163.0% year over year. Use the charts on this page to explore Skye Bioscience's operating income history and peer comparisons.

Skye Bioscience's operating income decreased from $-22M to $-59M — a 163.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Skye Bioscience reported $-59M in operating income as of March 2026. That compares with $-22M in the prior-year period — down 163.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-59M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Skye Bioscience, and consider following SKYE for alerts when major investors trade the stock.